Bridgebio Pharma Inc share price logo

Bridgebio Pharma Inc Share Price

NASDAQ: BBIO

Mid Cap

$51.84

+1.84

(+3.68%)

as on

Bridgebio Pharma Inc Stock Performance

as on September 4, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $50
    $52.5
    downward going graph

    3.55%

    Downside

    1.27%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $21.72
    $52.85
    downward going graph

    58.10%

    Downside

    1.94%

    Upside

    downward going graph

Bridgebio Pharma Inc share price movements today

Previous Close
$50.00
Open
$50.00
Volume
1.7M
Day's Low - High
$50 - $52.5
52 Week Low - High
$21.72 - $52.85

Bridgebio Pharma Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Bridgebio Pharma Inc Stock Fundamentals & Key Indicators

Check Bridgebio Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.9B

EPS (TTM)

-2.5934

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-10.2

Industry PE ratio

-9.23

P/B Ratio

0

PEG Ratio

0

EBITDA

-623.7M

Revenue (TTM)

235.8M

Profit Margin

0.00%

Return On Equity TTM

1545100.00%

Bridgebio Pharma Inc Stock Valuation

Track how Bridgebio Pharma Inc P/E has moved over time to understand its valuation trends.

Bridgebio Pharma Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 4, 2025

Today (-10.20x)

September 4, 2025

Industry (-9.23x)

September 4, 2025

Highest (0.00x)

September 4, 2025

LowHigh

Today’s Price to Earnings Ratio: -10.20x

Bridgebio Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bridgebio Pharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$9.9BNA-10.20.00%
BUY$58.6B264.27%-505.15-12.96%
NA$39.4BNANA-3.89%
BUY$101.7BNA28.2531.86%
BUY$59.8B-2.85%14.2131.37%

Analyst Recommendation on Bridgebio Pharma Inc Stock

Based on 20 analysts

BUY

85.00%

Buy

15.00%

Hold

0.00%

Sell

Based on 20 analysts, 85% of analysts recommend a 'BUY' rating for Bridgebio Pharma Inc. Average target price of $63.81

Bridgebio Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Bridgebio Pharma Inc.

What analysts predicted

18.76%UPSIDE

Target Price

$63.81

Current Price

$51.84

Analyzed by

20 Analysts

Target

$63.81

Bridgebio Pharma Inc target price $63.81, a slight upside of 18.76% compared to current price of $51.84. According to 20 analysts rating.

Bridgebio Pharma Inc Stock's Interest Amongst Investors

Search interest for Bridgebio Pharma Inc Stock has increased by 48% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:48% versus previous 30 day period

Bridgebio Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
1
1
4
1
211
2
2
5
116
110
Gross Profit
1
1
3
1
209
1
2
3
116
106
Operating Income
-126
-146
-157
-177
3
-175
-191
-226
-104
-133
EBITDA
-120
-138
-157
-148
-11
-51
-139
-235
-126
-142
Interest Expense
20
20
20
20
23
22
23
29
42
37
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-142
-160
-176
-170
-36
-75
-164
-266
-167
-181
Income Tax Expense
34
19
-1
18
0
-2
-
1
2
2
Net Income
-140
-157
-176
-168
-35
-73
-162
-265
-167
-181
Net Profit Margin
-7675.58%
-9622.12%
-4326.55%
-9635.99%
-16.68%
-3388.19%
-5931.19%
-4506.12%
-143.55%
-164.52%

Bridgebio Pharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
40
8
69
77
9
221
Gross Profit
0
-
38
5
66
74
6
218
Operating Income
-43
-183
-266
-474
-579
-471
-607
-592
EBITDA
-43
-183
-279
-465
-533
-397
-565
-436
Interest Expense
0
2
8
36
46
80
81
99
Depreciation
0
0
-
3
5
6
6
6
Income Before Tax
-43
-169
-288
-505
-586
-484
-653
-542
Income Tax Expense
-13
16
-28
-21
52
9
71
1
Net Income
-30
-130
-260
-448
-562
-481
-643
-535
Net Profit Margin
0.00%
0.00%
-642.10%
-5439.74%
-806.90%
-619.70%
-6913.92%
-241.44%

Bridgebio Pharma Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-160
-179
-170
-35
-73
-164
-267
-167
-183
Operating Cash Flow
-113
-145
-124
-219
74
-180
-195
-199
-80
Investing Cash Flow
4
37
0
22
3
38
-3
-1
-13
Financing Cash Flow
-1
307
-4
279
-5
0
473
60
302
Change in Cash
-110
199
-129
82
72
-141
275
-140
208

Bridgebio Pharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-169
-288
-505
-586
-484
-643
-543
Operating Cash Flow
-136
-253
-399
-497
-419
-527
-520
Investing Cash Flow
-21
-217
-52
-200
453
54
60
Financing Cash Flow
501
398
447
736
-13
451
748
Change in Cash
343
-72
-5
37
20
-22
288

Global Institutional Holdings in Bridgebio Pharma Inc

Funds
Holdings
Viking Global Investors LP
11.54%
Kohlberg Kravis Roberts & Co LP
10.08%
Vanguard Group Inc
7.79%
BlackRock Inc
6.99%
HHG PLC
3.75%

Bridgebio Pharma Inc News & Key Events

  • img

    Today's Timeline - 03 September

    Wed, 04:40 PM

    -

    H.C. Wainwright also maintains Buy rating, increasing price target from $56 to $70, with all analysts rating it Buy.

    Wed, 05:11 PM

    -

    J.P. Morgan maintains Buy rating on BridgeBio, raising price target to $70, citing strong pipeline and product launch.

Insights on Bridgebio Pharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, BBIO stock has moved up by 415.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, BBIO has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 78.4% return, outperforming this stock by 9.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -167.42M → -181.90M (in $), with an average decrease of 8.7% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 116.63M → 110.56M (in $), with an average decrease of 5.2% per quarter

About Bridgebio Pharma Inc

we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.
OrganisationBridgebio Pharma Inc
Headquarters3160 Porter Drive, Palo Alto, CA, United States, 94304
IndustryHealth Technology
CEODr. Neil Kumar Ph.D.
E-voting on sharesClick here to vote

Key Management of Bridgebio Pharma Inc

Name

Title

Dr. Thomas Trimarchi Ph.D.

CFO & President

Dr. Charles J. Homcy M.D.

Co-Founder, Chairman of Pharmaceuticals & Independent Lead Director

Ms. Maricel M. Apuli

Chief Accounting Officer

Dr. Uma Sinha Ph.D.

Chief Scientific Officer

Dr. Richard H. Scheller Ph.D.

Chairman of Research & Development

Dr. Neil Kumar Ph.D.

Co-Founder, CEO & Director

Dr. Frank P. McCormick Ph.D.

Co-Founder, Chairman of Oncology & Director

Mr. Eli M. Wallace Ph.D.

Chief Scientific Officer of Oncology

Dr. Eric Michael David J.D., M.D., Ph.D.

Chief Executive Officer of Gene Therapy

Mr. Matthew Outten CPC, MBA

Chief Commercial Officer

FAQs

What is Bridgebio Pharma Inc share price today?

Bridgebio Pharma Inc share price today is $51.84 as on at the close of the market. Bridgebio Pharma Inc share today touched a day high of $52.5 and a low of $50.

What is the 52 week high and 52 week low for Bridgebio Pharma Inc share?

Bridgebio Pharma Inc share touched a 52 week high of $52.85 on and a 52 week low of $21.72 on . Bridgebio Pharma Inc stock price today i.e. is closed at $51.84,which is 1.90% down from its 52 week high and 138.67% up from its 52 week low.

What is Bridgebio Pharma Inc's market capitalisation today?

Bridgebio Pharma Inc market capitalisation is $0.01T as on .

How to invest in Bridgebio Pharma Inc Stock (BBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bridgebio Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bridgebio Pharma Inc Shares that will get you 0.0289 shares as per Bridgebio Pharma Inc share price of $51.84 per share as on September 4, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bridgebio Pharma Inc Stock (BBIO) from India?

Indian investors can start investing in Bridgebio Pharma Inc (BBIO) shares with as little as ₹88.035 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.35 in Bridgebio Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Bridgebio Pharma Inc share’s latest price of $51.84 as on September 4, 2025 at 1:29 am IST, you will get 0.1929 shares of Bridgebio Pharma Inc. Learn more about fractional shares .